- Home
- SNSE vs INBS Comparison
SNSE vs INBS Comparison
Compare SNSE & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- INBS
- Stock Information
- Founded
- SNSE 2005
- INBS 2016
- Country
- SNSE United States
- INBS United States
- Employees
- SNSE N/A
- INBS N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- SNSE Health Care
- INBS Health Care
- Exchange
- SNSE Nasdaq
- INBS Nasdaq
- Market Cap
- SNSE 9.3M
- INBS 8.7M
- IPO Year
- SNSE 2021
- INBS N/A
- Fundamental
- Price
- SNSE $0.34
- INBS $1.66
- Analyst Decision
- SNSE Strong Buy
- INBS
- Analyst Count
- SNSE 4
- INBS 0
- Target Price
- SNSE $4.25
- INBS N/A
- AVG Volume (30 Days)
- SNSE 150.3K
- INBS 137.5K
- Earning Date
- SNSE 05-06-2025
- INBS 05-13-2025
- Dividend Yield
- SNSE N/A
- INBS N/A
- EPS Growth
- SNSE N/A
- INBS N/A
- EPS
- SNSE N/A
- INBS N/A
- Revenue
- SNSE N/A
- INBS $2,936,472.00
- Revenue This Year
- SNSE N/A
- INBS $280.88
- Revenue Next Year
- SNSE N/A
- INBS $126.26
- P/E Ratio
- SNSE N/A
- INBS N/A
- Revenue Growth
- SNSE N/A
- INBS 3.87
- 52 Week Low
- SNSE $0.25
- INBS $1.00
- 52 Week High
- SNSE $0.87
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- SNSE 50.22
- INBS 67.48
- Support Level
- SNSE $0.31
- INBS $1.35
- Resistance Level
- SNSE $0.33
- INBS $1.68
- Average True Range (ATR)
- SNSE 0.04
- INBS 0.10
- MACD
- SNSE 0.01
- INBS 0.04
- Stochastic Oscillator
- SNSE 75.25
- INBS 92.31
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).